Chunhong He

Person

Chadds Ford, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Heterocyclylamines as PI3K inhibitors
- Patent number 12,201,636
- Issue date Jan 21, 2025
- Incyte Corporation
- Yun-Long Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic urea compounds as JAK2 V617F inhibitors
- Patent number 12,084,430
- Issue date Sep 10, 2024
- Incyte Corporation
- Cooper Taylor
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazotriazines and imidazopyrimidines as kinase inhibitors
- Patent number 12,084,449
- Issue date Sep 10, 2024
- Incyte Holdings Corporation
- Jincong Zhuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazopyridazine and imidazopyridine compounds and uses thereof
- Patent number 12,030,889
- Issue date Jul 9, 2024
- Incyte Corporation
- Jun Pan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted tricyclic compounds as FGFR inhibitors
- Patent number 11,840,534
- Issue date Dec 12, 2023
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
- Patent number 11,673,894
- Issue date Jun 13, 2023
- Incyte Corporation
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolotriazine compounds as TAM inhibitors
- Patent number 11,591,338
- Issue date Feb 28, 2023
- Incyte Corporation
- Yun-Long Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic heterocycles as FGFR inhibitors
- Patent number 11,530,214
- Issue date Dec 20, 2022
- Incyte Holdings Corporation
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazopyridazine and imidazopyridine compounds and uses thereof
- Patent number 11,459,329
- Issue date Oct 4, 2022
- Incyte Corporation
- Jun Pan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclylamines as PI3K inhibitors
- Patent number 11,433,071
- Issue date Sep 6, 2022
- Incyte Corporation
- Yun-Long Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazopyridazine and imidazopyridine compounds and uses thereof
- Patent number 11,427,592
- Issue date Aug 30, 2022
- Incyte Corporation
- Jun Pan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds as LSD1 inhibitors
- Patent number 11,401,272
- Issue date Aug 2, 2022
- Incyte Corporation
- Chunhong He
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazotriaines and imidazopyrimidines as kinase inhibitors
- Patent number 11,261,191
- Issue date Mar 1, 2022
- Incyte Holdings Corporation
- Jincong Zhuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclopropylamines as LSD1 inhibitors
- Patent number 11,247,992
- Issue date Feb 15, 2022
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrole tricyclic compounds as A2A / A2B inhibitors
- Patent number 11,220,510
- Issue date Jan 11, 2022
- Incyte Corporation
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolopyrimidine derivatives as TAM inhibitors
- Patent number 11,136,326
- Issue date Oct 5, 2021
- Incyte Corporation
- Yun-Long Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted tricyclic compounds as FGFR inhibitors
- Patent number 11,053,246
- Issue date Jul 6, 2021
- Incyte Corporation
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors
- Patent number 10,919,901
- Issue date Feb 16, 2021
- Incyte Holdings Corporation
- Jincong Zhuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolotriazine compounds as TAM inhibitors
- Patent number 10,844,069
- Issue date Nov 24, 2020
- Incyte Corporation
- Yun-Long Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazopyridazines and benzimidazoles as inhibitors of...
- Patent number 10,813,930
- Issue date Oct 27, 2020
- Incyte Corporation
- Wenqing Yao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as LSD1 inhibitors
- Patent number 10,800,779
- Issue date Oct 13, 2020
- Incyte Corporation
- Chunhong He
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazotriaines and imidazopyrimidines as kinase inhibitors
- Patent number 10,738,052
- Issue date Aug 11, 2020
- Incyte Holdings Corporation
- Jincong Zhuo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropylamines as LSD1 inhibitors
- Patent number 10,717,737
- Issue date Jul 21, 2020
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyridines and imidazopyrazines as LSD1 inhibitors
- Patent number 10,640,503
- Issue date May 5, 2020
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
- Patent number 10,556,908
- Issue date Feb 11, 2020
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolopyrimidine derivatives as TAM inhibitors
- Patent number 10,519,163
- Issue date Dec 31, 2019
- Incyte Corporation
- Yun-Long Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropylamines as LSD1 inhibitors
- Patent number 10,513,493
- Issue date Dec 24, 2019
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors
- Patent number 10,472,367
- Issue date Nov 12, 2019
- Incyte Incorporation
- Jincong Zhuo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heterocycles as FGFR inhibitors
- Patent number 10,450,313
- Issue date Oct 22, 2019
- Incyte Holdings Corporation
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolotriazine compounds as TAM inhibitors
- Patent number 10,442,810
- Issue date Oct 15, 2019
- Incyte Corporation
- Yun-Long Li
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
TRICYCLIC UREA COMPOUNDS AS JAK2 V617F INHIBITORS
- Publication number 20250122170
- Publication date Apr 17, 2025
- INCYTE CORPORATION
- Cooper Taylor
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic Ureas As Kinase Inhibitors
- Publication number 20240317744
- Publication date Sep 26, 2024
- INCYTE CORPORATION
- Xin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIDAZINE AND IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
- Publication number 20240309008
- Publication date Sep 19, 2024
- INCYTE CORPORATION
- Jun Pan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS
- Publication number 20240246974
- Publication date Jul 25, 2024
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLYLAMINES AS PI3K INHIBITORS
- Publication number 20240216377
- Publication date Jul 4, 2024
- INCYTE CORPORATION
- Yun-Long Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS
- Publication number 20240124463
- Publication date Apr 18, 2024
- INCYTE CORPORATION
- Yun-Long Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20230357255
- Publication date Nov 9, 2023
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC UREA COMPOUNDS AS JAK2 V617F INHIBITORS
- Publication number 20230295124
- Publication date Sep 21, 2023
- INCYTE CORPORATION
- Cooper Taylor
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR
- Publication number 20230226040
- Publication date Jul 20, 2023
- INCYTE CORPORATION
- Alejandro Amador Arjona
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLYLAMINES AS PI3K INHIBITORS
- Publication number 20230121440
- Publication date Apr 20, 2023
- INCYTE CORPORATION
- Yun-Long Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20230056631
- Publication date Feb 23, 2023
- INCYTE CORPORATION
- Pei Gan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Imidazotriazines and Imidazopyrimidines as Kinase Inhibitors
- Publication number 20230002392
- Publication date Jan 5, 2023
- INCYTE CORPORATION
- Jincong Zhuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZOPYRIDAZINE AND IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
- Publication number 20220315595
- Publication date Oct 6, 2022
- INCYTE CORPORATION
- Jun Pan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLE TRICYCLIC COMPOUNDS AS A2A / A2B INHIBITORS
- Publication number 20220213112
- Publication date Jul 7, 2022
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20220213090
- Publication date Jul 7, 2022
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20220194931
- Publication date Jun 23, 2022
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROCYCLES AS FGFR INHIBITORS
- Publication number 20210395246
- Publication date Dec 23, 2021
- INCYTE CORPORATION
- Yaping Sun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS
- Publication number 20210380587
- Publication date Dec 9, 2021
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20210269434
- Publication date Sep 2, 2021
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS
- Publication number 20210147430
- Publication date May 20, 2021
- INCYTE CORPORATION
- Yun-Long Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20210107900
- Publication date Apr 15, 2021
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLOPROPYLAMINES AS LSD1 INHIBITORS
- Publication number 20210032244
- Publication date Feb 4, 2021
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLOPROPYLAMINES AS LSD1 INHIBITORS
- Publication number 20210024487
- Publication date Jan 28, 2021
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS
- Publication number 20200392143
- Publication date Dec 17, 2020
- INCYTE CORPORATION
- Chunhong He
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS
- Publication number 20200377504
- Publication date Dec 3, 2020
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLYLAMINES AS PI3K INHIBITORS
- Publication number 20200323858
- Publication date Oct 15, 2020
- INCYTE CORPORATION
- Yun-Long Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Imidazotriaines and Imidazopyrimidines as Kinase Inhibitors
- Publication number 20200317680
- Publication date Oct 8, 2020
- INCYTE CORPORATION
- Jincong Zhuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZO[1,2-B][1,2,4]TRIAZINES AS C-MET INHIBITORS
- Publication number 20200247811
- Publication date Aug 6, 2020
- Incyte Holdings Corporation
- Jincong Zhuo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIDAZINE AND IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
- Publication number 20200199131
- Publication date Jun 25, 2020
- INCYTE CORPORATION
- Jun Pan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOPYRIMIDINE DERIVATIVES AS TAM INHIBITORS
- Publication number 20200181151
- Publication date Jun 11, 2020
- INCYTE CORPORATION
- Yun-Long Li
- C07 - ORGANIC CHEMISTRY

Chunhong He

Person

Patents Grantslast 30 patents

Heterocyclylamines as PI3K inhibitors

Tricyclic urea compounds as JAK2 V617F inhibitors

Imidazotriazines and imidazopyrimidines as kinase inhibitors

Imidazopyridazine and imidazopyridine compounds and uses thereof

Substituted tricyclic compounds as FGFR inhibitors

Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors

Pyrrolotriazine compounds as TAM inhibitors

Bicyclic heterocycles as FGFR inhibitors

Imidazopyridazine and imidazopyridine compounds and uses thereof

Heterocyclylamines as PI3K inhibitors

Imidazopyridazine and imidazopyridine compounds and uses thereof

Heterocyclic compounds as LSD1 inhibitors

Imidazotriaines and imidazopyrimidines as kinase inhibitors

Cyclopropylamines as LSD1 inhibitors

Pyrrole tricyclic compounds as A2A / A2B inhibitors

Pyrrolopyrimidine derivatives as TAM inhibitors

Substituted tricyclic compounds as FGFR inhibitors

Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors

Pyrrolotriazine compounds as TAM inhibitors

Substituted imidazopyridazines and benzimidazoles as inhibitors of...

Heterocyclic compounds as LSD1 inhibitors

Imidazotriaines and imidazopyrimidines as kinase inhibitors

Cyclopropylamines as LSD1 inhibitors

Imidazopyridines and imidazopyrazines as LSD1 inhibitors

Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors

Pyrrolopyrimidine derivatives as TAM inhibitors

Cyclopropylamines as LSD1 inhibitors

Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors

Bicyclic heterocycles as FGFR inhibitors

Pyrrolotriazine compounds as TAM inhibitors

Patents Applicationslast 30 patents

TRICYCLIC UREA COMPOUNDS AS JAK2 V617F INHIBITORS

Bicyclic Ureas As Kinase Inhibitors

IMIDAZOPYRIDAZINE AND IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF

SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS

HETEROCYCLYLAMINES AS PI3K INHIBITORS

PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS

IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

TRICYCLIC UREA COMPOUNDS AS JAK2 V617F INHIBITORS

COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR

HETEROCYCLYLAMINES AS PI3K INHIBITORS

TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS

Imidazotriazines and Imidazopyrimidines as Kinase Inhibitors

IMIDAZOPYRIDAZINE AND IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF

PYRROLE TRICYCLIC COMPOUNDS AS A2A / A2B INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

BICYCLIC HETEROCYCLES AS FGFR INHIBITORS

SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS

TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS

PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

CYCLOPROPYLAMINES AS LSD1 INHIBITORS

CYCLOPROPYLAMINES AS LSD1 INHIBITORS

HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS

SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS

HETEROCYCLYLAMINES AS PI3K INHIBITORS

Imidazotriaines and Imidazopyrimidines as Kinase Inhibitors

IMIDAZO[1,2-B][1,2,4]TRIAZINES AS C-MET INHIBITORS

IMIDAZOPYRIDAZINE AND IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF

PYRROLOPYRIMIDINE DERIVATIVES AS TAM INHIBITORS